Robertson Stephens Wealth Management, LLC

Holdings History for Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

Symbol: CUE on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$146,134	478,500	0		$0.31	Q4 2025
30 Sep 2025	0.01%	0%	$343,898	478,500	0		$0.72	Q3 2025
30 Jun 2025	0.01%	0%	$326,481	478,500	0		$0.68	Q2 2025
31 Mar 2025	0.02%	0%	$435,914	478,500	0		$0.91	Q1 2025
31 Dec 2024	0.02%	0%	$521,565	478,500	0		$1.09	Q4 2024
30 Sep 2024	0.01%	0%	$362,320	478,500	0		$0.76	Q3 2024
30 Jun 2024	0.03%	0%	$593,340	478,500	0		$1.24	Q2 2024
31 Mar 2024	0.05%	0%	$904,365	478,500	0		$1.89	Q1 2024
31 Dec 2023	0.08%	0%	$1,263,240	478,500	0		$2.64	Q4 2023
30 Sep 2023	0.07%	0%	$1,100,550	478,500	0		$2.30	Q3 2023
30 Jun 2023	0.13%	0%	$1,746,525	478,500	0		$3.65	Q2 2023
31 Mar 2023	0.15%	0%	$1,708,245	478,500	0		$3.57	Q1 2023
31 Dec 2022	0.13%	0%	$1,363,725	478,500	0		$2.85	Q4 2022
30 Sep 2022	0.12%	0%	$1,067,000	478,500	0		$2.23	Q3 2022
30 Jun 2022	0.12%	0%	$1,191,000	478,500	0		$2.49	Q2 2022
31 Mar 2022	0.2%	0%	$2,335,000	478,500	0		$4.88	Q1 2022
31 Dec 2021	0.46%	0%	$5,411,000	478,500	0		$11.31	Q4 2021
30 Sep 2021	0.81%	0%	$6,971,000	478,500	0		$14.57	Q3 2021
30 Jun 2021	0.67%	0%	$5,574,000	478,500	0		$11.65	Q2 2021
31 Mar 2021	0.93%	-0.01%	$5,837,000	478,500	-5,500	-1.1%	$12.20	Q1 2021
31 Dec 2020	1.3%	0%	$6,054,000	484,000	0		$12.51	Q4 2020
30 Sep 2020	1.8%	+1.8%	$7,284,000	484,000	+484,000	NEW	$15.05	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.